ZEVALIN (IBRITUMOMAB TIUXETAN) — FDA Approval BLA125019 (SPECTRUM PHARMS)
ZEVALIN (IBRITUMOMAB TIUXETAN) — FDA Approval BLA125019 (SPECTRUM PHARMS) is one of 9,000 drug approvals in the DrugApprovals dataset. Key details — Brand name: ZEVALIN; Active ingredients: IBRITUMOMAB TIUXETAN; Application number: BLA125019.
| Brand name | ZEVALIN |
|---|---|
| Active ingredients | IBRITUMOMAB TIUXETAN |
| Application number | BLA125019 |
| Sponsor | SPECTRUM PHARMS |
| Dosage form | INJECTABLE |
| Route | INJECTION |
| Marketing status | Prescription |
| Products in application | 1 |
| First approval date | 20020219 |
| Source | openFDA Drugs@FDA |
$1499/mo
Try DrugApprovals →